Multi drug resistant tuberculosis: at the cross road in India

Authors

  • Khadanga S Associate Professor, Department of Medicine, LN Medical College, Bhopal, Madhya Pradesh, India.
  • Karuna T Assistant Professor, Department of Microbiology, AIIMS, Bhopal, Madhya Pradesh, India.
  • Behera S Associate Professor, Department of TB and Chest, Hi tech Medical College, Bhubaneswar, Odisha, India.
  • Dugar D Assistant Professor, Department of Surgery, Hi tech Medical College, Bhubaneswar, Odisha, India.

Keywords:

MDR, Tuberculosis, Prevention, National Programme

Abstract

Tuberculosis is endemic disease in India. Prevalence is very high and one third of our population is infected with this disease. Emergence of MDR form of Mycobacterium bacilli has further deteriorating Indian scenario. In this article we have discussed prevalence & preventive strategies for MDR form of Tuberculosis.

References

Proceedings of the Tuberculosis, Association of India. Tuberculosis Association of India; 1939. Cited at: www.tbfacts.org/tb-india-history.html on 20th May 2014.

Proceedings of 5 th All India BCG Conference, 1962; Bangalore, India.

Theglobalfund.org [Internet]. The Global Fund to fight AIDS, Tuberculosis and Malaria; Available from:http://www.theglobalfund.org/en/commitmentsdisbu rsements/?lang=eng

World Health Organization. Joint TB Programme Review-India: WHO, SEARO-TB-224. Geneva: WHO; 2000.

Sandhu GK. Tuberculosis: Current situation, challenges and overview of its control programs in India. J Global Infect Dis 2011; 3:143-50.

Revised National Tuberculosis Control Programme. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India-2012. Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare.

World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2009.

World Health Organization. THE GLOBAL PLAN TO STOP TB 2006-2015: PART I Strategic directions. Geneva:WHO; 2006.Available from: http://www. searo.who.int/ LinkFiles/ TB_Day_Kit_The_Global_Plan_to_Stop_TB_2006- 2015.pdf

World Health Organization. The WHO/ IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report No. 2. Geneva: WHO; 2000.

World Health Organization. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Report No. 3. Geneva: WHO; 2003.

WHO. Global Tuberculosis Report 2012. Available at http://www.who.int/tb/publications/global_report/en/inde x.html.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR,Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009: 13(9); 1154- 1160.

World Health Organisation. Multidrug-resistant tuberculosis (MDR-TB); 2012 Update

Downloads

Published

2023-12-31

How to Cite

Khadanga, S., Karuna, T., Behera, S. K., & Dugar, D. (2023). Multi drug resistant tuberculosis: at the cross road in India. Biomedical Review: Journal of Basic and Applied Medical Sciences, 1(1), 32–35. Retrieved from https://biomedicalreview.in/index.php/jbams/article/view/7

Issue

Vol. 1 No. 1 (2014): Apr-Jun

Section

Short Communication

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Biomedical Review follows the Creative Commons CC-BY license (Attribution). It means Authors can use, reuse and build upon the material published in the journal but only for non-commercial purposes. Every article published in the Journal clearly mentioned licensing terms between author/authors and publisher (Siddharth Health Research and Social Welfare Society) as the logo of Creative Commons CC-BY license (Attribution) https://creativecommons.org/licenses/by/4.0/.